FDA removes hold on clinical trial for phase 2,3 for COVAXIN-BBV152 says Ocugen

May 23, 2022

Malvern (Pennsylvania) [US], May 23 : Biotechnology company Ocugen on Monday announced that the US Food and Drug Administration (FDA) lifted the clinical hold...

Ocugen to commercialize Covaxin in Mexico, rights now encompassing all of North America

Apr 18, 2022

Malvern (Pennsylvania) [US]/ Hyderabad (Telangana) [India], April 18 : Biotechnology company Ocugen and Bharat Biotech (BBIL), on Monday, announced that they have entered into...

Ocugen Inc to have exclusive co-development, manufacturing rights of Covaxin in Canada: Bharat Biotech

Jun 03, 2021

Hyderabad (Telangana) [India], June 3 : Hyderabad-based Bharat Biotech on Thursday said that biopharmaceutical company Ocugen Inc will have exclusive co-development, manufacturing, and commercialisation...

Bharat Biotech's US partner, Ocugen to apply for full approval for Covaxin

Jun 11, 2021

Pennsylvania [US], June 11 : Bharat Biotech's US partner Ocugen Inc said that the company will no longer pursue an Emergency Use Authorization (EUA)...

BioNTech to produce 2 billion doses of COVID-19 vaccine in 2021 amid surge in global demand

Feb 02, 2021

Mainz [Germany], February 2 : German biotechnology company BioNTech is planning to produce two billion doses of COVID-19 vaccine in 2021 because of the...

Bharat Biotech donates 2 lakh Covaxin doses to Vietnam

Dec 16, 2021

New Delhi [India], December 16 : Hyderabad-based biotechnology company Bharat Biotech on Thursday announced that it will donate two lakh doses of its COVID-19...